OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4
Liquan Zhu, Shiqi Hu, Xiaoqiao Yan, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106461-106461
Closed Access | Times Cited: 13
Liquan Zhu, Shiqi Hu, Xiaoqiao Yan, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106461-106461
Closed Access | Times Cited: 13
Showing 13 citing articles:
Current advances and development strategies of orally bioavailable PROTACs
Shenxin Zeng, Yingqiao Ye, Heye Xia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115793-115793
Closed Access | Times Cited: 32
Shenxin Zeng, Yingqiao Ye, Heye Xia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115793-115793
Closed Access | Times Cited: 32
Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
ZX703: A Small-Molecule Degrader of GPX4 Inducing Ferroptosis in Human Cancer Cells
Mengdie Hu, Xiaomei Li, Lin Wang, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 3, pp. 406-412
Closed Access | Times Cited: 5
Mengdie Hu, Xiaomei Li, Lin Wang, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 3, pp. 406-412
Closed Access | Times Cited: 5
Research progress on GPX4 targeted compounds
Bingru Li, Keguang Cheng, T. Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116548-116548
Closed Access | Times Cited: 5
Bingru Li, Keguang Cheng, T. Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116548-116548
Closed Access | Times Cited: 5
Design, Synthesis, and Biological Evaluation of Hydrophobic-Tagged Glutathione Peroxidase 4 (GPX4) Degraders
Xiaomei Li, Mengdie Hu, Yanping Zhang, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107115-107115
Closed Access | Times Cited: 4
Xiaomei Li, Mengdie Hu, Yanping Zhang, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107115-107115
Closed Access | Times Cited: 4
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 4
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 4
Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment
Lianlian Fan, Weifang Tong, Anhui Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133680-133680
Open Access | Times Cited: 2
Lianlian Fan, Weifang Tong, Anhui Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133680-133680
Open Access | Times Cited: 2
Design, Synthesis, and Biological Evaluation of RSL3-based GPX4 Degraders with Hydrophobic Tags
Yao Ning, Zeqi Zhu, Yi‐Cheng Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116719-116719
Closed Access | Times Cited: 2
Yao Ning, Zeqi Zhu, Yi‐Cheng Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116719-116719
Closed Access | Times Cited: 2
A prospective therapeutic strategy: GPX4-targeted ferroptosis mediators
Jia-Yu Qian, Chao-Yuan Lou, Yili Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117015-117015
Closed Access | Times Cited: 1
Jia-Yu Qian, Chao-Yuan Lou, Yili Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117015-117015
Closed Access | Times Cited: 1
Unveiling a new strategy for PDIA1 inhibition: Integration of activity-based probes profiling and targeted degradation
Bei Zhang, Dawei Hong, Hujuan Qian, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107585-107585
Closed Access
Bei Zhang, Dawei Hong, Hujuan Qian, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107585-107585
Closed Access
PROTAC as a novel anti-cancer strategy by targeting aging-related signaling
Yunhua Peng, Donghua Liu, Daoyuan Huang, et al.
Seminars in Cancer Biology (2024)
Closed Access
Yunhua Peng, Donghua Liu, Daoyuan Huang, et al.
Seminars in Cancer Biology (2024)
Closed Access
An overview of GPX4-targeting TPDs for cancer therapy
Xiaojuan Yang, Liqiang Wu, Shaohong Xu
Bioorganic & Medicinal Chemistry (2024) Vol. 118, pp. 118046-118046
Closed Access
Xiaojuan Yang, Liqiang Wu, Shaohong Xu
Bioorganic & Medicinal Chemistry (2024) Vol. 118, pp. 118046-118046
Closed Access
